
Keywords: ASCO, American Society of Clinical Oncology; ASH, American Society of Hematology; ALL, acute lymphoblastic leukemia; ALCL, anaplastic large cell lymphoma; ADCC, antibody-dependent cellular cytotoxicity; ADC, antibody–drug conjugate; BM, bone marrow; CAR-T